OrthoSensor Announces Key Senior Executive Appointments
Industry Veterans to Bolster Company’s Expanding Sales, Marketing and Product Development Initiatives
Ft. Lauderdale, FL, (July 25, 2013) – OrthoSensor, Inc., the leader in intelligent orthopaedics, announced today that it has appointed two industry veterans to its executive team. Douglas Leach has joined the company as Executive Vice President, Marketing and Product Development, and Rich McKillop has been named Senior Vice President, Global Sales.
Leach joins OrthoSensor after more than 27 years experience in orthopaedic sales, marketing and product development with Stryker Orthopaedics. Holding roles in both the United States and abroad, Leach most recently served as Vice President, Global Knees and Biomaterials Research and Development, and previously held the role of Vice President, Knee Marketing for Stryker.
McKillop comes to OrthoSensor with more than 20 years of sales and general management experience in the orthopaedic industry, most recently as a senior executive with Conmed/Linvatech Corporation where he served as Vice President of Sales, North American and previously as General Manager, Canada. Prior to joining Conmed, McKillop held increasingly progressive roles in sales and marketing with Howmedica and Wright Medical.
“We are extremely pleased to announce these two key additions to the OrthoSensor leadership team,” said President and Chief Executive Officer Jay Pierce. “Doug and Rich will help us build on the momentum that we have established. They will be invaluable as we continue to execute on our strategic growth plans and leverage our unique technologies to positively impact orthopaedics and healthcare.”
OrthoSensor, Inc. (www.orthosensor.com) is developing and commercializing intelligent orthopedic devices that provide real-time data to surgeons and hospitals during and after surgery. OrthoSensor’s intelligent orthopedic devices utilize advanced sensor and wireless communication technologies with the goal of improving healthcare outcomes and reducing the cost of treating musculoskeletal disease. The company’s intelligent orthopedic instrumentation and implants are designed to enhance surgical implantation, and enable remote monitoring of implant function and overall musculoskeletal health.